Forget Mylan: The Government Should Focus On Mallinckrodt

Forget Mylan: The Government Should Immediately Investigate Mallinckrodt – A Personal Blog Post by Christopher Irons for GeoInvesting, @QTRResearch

• Mallinckrodt’s Acthar Gel may turn out to be the most appalling story in all of price gouging and it has gone completely unnoticed by politicians and the main stream media
• Price of the drug has gone from $40 per vial in 2001 to $28,000, an over 70,000% increase
• A good portion of Mallinckrodt’s sales come from this 64 year old drug that has skirted modern FDA trials, recently failed a pilot study, and lacks double blind clinical trials versus (a much cheaper) synthetic
• The company is in the same district as Sen. Claire McCaskill and is a...
  

  Login required to continue reading.

  Setup a free account to get access to this article (no credit card required).

  View Full Article

  Already a member? Log in here